The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Trumenba



Pfizer Europe MA EEIGEU/1/17/1187/001-006

Main Information

Trade NameTrumenba
Active SubstancesNeisseria meningitidis serogroup b recombinant lipoprotein (rlp2086; sub family a)
Neisseria meningitidis serogroup b recombinant lipoprotein (rlp2086; sub family b)
Dosage FormSuspension for injection in pre-filled syringe
Licence HolderPfizer Europe MA EEIG
Licence NumberEU/1/17/1187/001-006

Group Information

ATC CodeJ07AH Meningococcal vaccines
J07AH09 meningococcus B, multicomponent vaccine

Status

License statusAuthorised
Licence Issued
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back